Pyrolidium dithiocarbamate prevents shockwave lithotripsy-induced renal injury through inhibition of nuclear factor-kappa B and inducible nitric oxide synthase activity in rats

Journal of Endourology

Volumn 22, Issue 3, 2008, Pages 559-566

  Tugcu, Vulcan ^a   Bas, Muzaffer ^a   Ozbeck, Emin ^b   Kemahli, Emay ^a   Arinci, Yasar Volkan ^c   Tuhri, Mehmet ^a   Altug, Tuncay ^d   Tasci, Ali Ihsan ^a  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Vakif Gureba Research and Education Hospital   (Turkey)

^c ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FORMALDEHYDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCLONAL ANTIBODY; PYROLIDIUM DITHIOCARBAMATE; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY NECROSIS; KIDNEY PARENCHYMA; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; STATISTICAL SIGNIFICANCE;

ANIMALS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY TUBULES; LITHOTRIPSY; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; THIOCARBAMATES;

EID: 41149090237     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.0295     Document Type: Article

References (41)

1. Li X, He D, Zhang L, Xue Y, Cheng X, Luo Y. Pyrrolidine dithiocarbamate attenuates shock wave induced MDCK cells injury via inhibiting nuclear factor-kappa B activation. Urol Res 2007;35:193-199.
2. Delius M, Enders G, Xuan Z, Liebich HG, Brendel W. Biological effects of shock waves: Kidney damage by shock waves in dogs - dose dependence. Ultrasound Med Biol 1988;14:117-122.
3. Dunn F. Cellular inactivation by heat and shear. Radiat Environ Biophys 1985;24:131-139.
4. Moran ME, Hynynen K, Bottaccini MR, Drach GW. Cavitation and thermal phenomena associated with high energy shock waves - in vitro and in vivo measurements. J Urol 1990;142:388.
5. Morgan TR, Laudone VP, Heston WDW, Zeitz L, Fair WR. Free radical production by high energy shock waves - comparison with ionizing irradiation. J Urol 1988;139:186-189.
6. Suhr D, Brummer F, Hulser DF. Cavitation-generated free radicals during shock wave exposure: Investigations with cell-free solutions and suspended cells. Ultrasound Med Biol 1991;17:761-768.
7. Strohmaier WL, Lahme S, Weidenbach PM, Bichler KH. Reduction of high-energy shock-wave-induced renal tubular injury by selenium. Urol Res 1999;27:382-385.
8. Crum LA. Cavitation microjets as a contributory mechanism for renal calculi disintegration in ESWL. J Urol 1988;140:1587-1590.
9. Serel TA, Ozguner F, Soyupek S. Prevention of shock wave-induced renal oxidative stress by melatonin: An experimental study. Urol Res 2004;32:69-71.
10. Baldwin AS. The NFκ-B and kappa B proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-681.
11. Ghosh S, May MJ, Kopp EB. NFκ-B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;13:225-260.
12. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999;18:6910-6924.
13. Pahl HL. Activators and target genes of Rel/NFκ-B transcription factors. Oncogene 1999;18:6953-6866.
14. Schreck R, Rieber R, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-2258.
15. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-4708.
16. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest 1993;91:2138-2143.
17. Fischer PA, Dominguez GN, Cuniberti LA, et al. Hyperhomocysteinemia induces renal hemodynamic dysfunction: Is nitric oxide involved? J Am Soc Nephrol 2003;14:653-660.
18. Hiue RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 1993;18:195-199.
19. Ignarro LJ. Introduction and overview. In: Ignarro LJ (ed): Nitric Oxide Biology and Pathobiology. San Diego: Academic Press, 2000, pp 3-19.
20. Elman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
21. Houghton DC, Plamp CE, DeFehr JM, Bennett WM, Porter G, Gilbert D. Gentamicin and tobramicin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol 1978;93:137-152.
22. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-130.
23. Sokolov DL, Bailey MR, Crum LA, Blomgren PM, Connors BA, Evan AP. Prefocal alignment improves stone comminution in shockwave lithotripsy. J Endourol 2002;16:709-715.
24. Rovin BH, Wurst E, Kohan DE. Production of reactive oxygen species by tubular epithelial cells in culture. Kidney Int 1990;37:1509-1514.
25. Özgüner F, Armagan A, Koyu A, Çaļskan S, Koylu H. A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress. Urol Res 2005;33:239-243.
26. Strohmaier WL, Bichler KH, Deetjen P, Kleinknecht S, Pedro M, Wilbert DM. Damaging effects of high energy shock waves on cultured Madin Darby canine kidney (MDCK) cells. Urol Res 1990;18:255-258.
27. Strohmaier WL, Pedro M, Wilbert DM, Bichler KH. Reduction of shock wave-induced tubular alteration by fosfomycin. J Endourol 1991;5:57.
28. Strohmaier WL, Koch J, Wilbert DM, Bichler KH. Beneficial effect of verapamil on shock wave induced tubular damage (abstract). Abstracts of the Xth Congress of the European Association of Urology, Genua, 1992, p 7.
29. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993;12:2005-2015.
30. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factorkappa B activation and neutrophilic lung inflammation. J Immunol 1996;157:1630-1637.
31. Moine P, Shenkar R, Kaneko D, Le Tulzo Y, Abraham E. Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs. Am J Physiol 1997;273(1 Pt 1):L185-L192.
32. Shenkar R, Abraham E. Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol 1997;16:145-152.
33. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, Abraham E. Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J Immunol 1996;157:3902-3908.
34. Lieberthal W. Biology of ischemic and toxic renal tubular cell injury: Role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 1998;7:289-295.
35. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota filipe H, Thiemermann C. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002;61:862-871.
36. Davis KL, Martin E, Turko IV, Murad F. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 2001;41:203-236
37. Wink DA, Mitchell JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25(4-5):434-456.
38. Romagnani P, Pupilli C, Lasagni L, et al. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. J Pathol 1999;187:345-350.
39. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002;61:855-861.
40. Zhang F, Siow YL, O K. Hyperhomocysteinemia activates NF-kappaB and inducible nitric oxide synthase in the kidney. Kidney Int 2004;65:1327-1338.
41. Skálová S. The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove) 2005;48:75-80.